Safety and efficacy of miltefosine alone and in combination with sodium stibogluconate and liposomal amphotericin B for the treatment of primary visceral leishmaniasis in East Africa: study protocol for a randomized controlled trial.

Safety and efficacy of miltefosine alone and in combination with sodium stibogluconate and liposomal amphotericin B for the treatment of primary visceral leishmaniasis in East Africa: study protocol for a randomized controlled trial.

Item

http://www.wikidata.org/entity/Q35163598

Q35163598

about

Recent developments and future prospects in the treatment of visceral leishmaniasis Miltefosine for visceral and cutaneous leishmaniasis: drug characteristics and evidence-based treatment recommendations Miltefosine: a review of its pharmacology and therapeutic efficacy in the treatment of leishmaniasis Leishmania donovani develops resistance to drug combinations Safety and efficacy of single dose versus multiple doses of AmBisome for treatment of visceral leishmaniasis in eastern Africa: a randomised trial Efficacy and Safety of AmBisome in Combination with Sodium Stibogluconate or Miltefosine and Miltefosine Monotherapy for African Visceral Leishmaniasis: Phase II Randomized Trial Leishmaniasis: an update of current pharmacotherapy.Developments in diagnosis and treatment of visceral leishmaniasis during the last decade and future prospects.Host-mediated Leishmania donovani treatment using AR-12 encapsulated in acetalated dextran microparticles.An update on pharmacotherapy for leishmaniasis Generalizing boundaries for triangular designs, and efficacy estimation at extended follow-ups.Validation and Clinical Evaluation of a Novel Method To Measure Miltefosine in Leishmaniasis Patients Using Dried Blood Spot Sample Collection.Triangular test design to evaluate tinidazole in the prevention of Plasmodium vivax relapse Therapeutic options for visceral leishmaniasis.The economic burden of visceral leishmaniasis in Sudan: an assessment of provider and household costs.Five-year retrospective Italian multicenter study of visceral leishmaniasis treatment.Drug resistance in leishmaniasis: Newer developments.Combination therapy with tamoxifen and amphotericin B in experimental cutaneous leishmaniasis.New perspectives for leishmaniasis chemotherapy over current anti-leishmanial drugs: a patent landscape.Chemotherapy of leishmaniasis: present challenges.Nanotized Curcumin and Miltefosine, a Potential Combination for Treatment of Experimental Visceral Leishmaniasis.Efficacy of tamoxifen and miltefosine combined therapy for cutaneous leishmaniasis in the murine model of infection with Leishmania amazonensis.Translational pharmacokinetic modelling and simulation for the assessment of duration of contraceptive use after treatment with miltefosine.Drug resistance and treatment failure in leishmaniasis: A 21st century challenge.Visceral Leishmaniasis - Current Treatments and Needs

P2860

Q26740563-9CEA19CA-169E-4366-9B5C-F0390E19CCD6 Q28088410-FBCCF3CD-6D3D-4F40-9A32-8E6C7E31448B Q28271849-973CFC05-B5E4-4E72-9D4C-B621ADB44C0B Q28484463-3E98BD46-DBD8-4D93-8AB9-01AFBFE6D06C Q28538775-3953F87F-1AA6-4FA2-A0D9-B4E88C870114 Q28554069-36A15FA6-E850-401B-8267-9A7565CE56BB Q34318765-DECE6034-4D47-4BAA-A563-7FD75B643BE3 Q34328882-9DA7E212-9920-438B-BF68-D359C5A52C1B Q34509079-27B3F93D-A3B9-4431-A80D-E488CC71F081 Q34945204-8B97F79A-C83F-4A2D-A27B-8373AF25563C Q36287224-5F406940-501A-45B7-B2FC-B6AF657EA807 Q36730131-8112EE76-D5B7-40A8-81FF-693CDF753B37 Q36898219-E289189D-3523-4E33-9C74-7F6B5EB19CE6 Q37333942-F3E02436-5FA8-4DCB-95FA-6955FC6CF0BA Q37372627-A1DCFE44-20B0-4501-8924-FC40745F28ED Q37544514-994CE1E7-267B-46B3-9292-2CAB53BBE4C7 Q37712190-6AD87789-7625-42C2-9CF7-CCBBFADC12BE Q37712995-320003A2-B834-4DDF-9716-3FCDF6A78C38 Q38296306-16436BD3-9CB0-49ED-81DF-EEAF0C0C943C Q39011875-5897CED8-F7CE-4814-817D-6A7DEE6A58F7 Q39526125-AC2C5600-94B1-48BA-9CB6-392A84C728E1 Q40802236-5FB71C8E-ADCB-4FD3-942F-CEFB89407CE3 Q43577504-5BC60360-90EB-482D-A834-2EE22E464F11 Q46380663-3825BF01-A9EE-45CA-A0E2-968702CA506D Q59003562-2A6D5A97-7F7C-4CE4-843F-3B797624F78A

P2860

Safety and efficacy of miltefosine alone and in combination with sodium stibogluconate and liposomal amphotericin B for the treatment of primary visceral leishmaniasis in East Africa: study protocol for a randomized controlled trial.

Item

http://www.wikidata.org/entity/Q35163598

description

2011 nî lūn-bûn

@nan

2011 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի հունիսին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu